Skip to main content
Medical information Clinical review pending

Infection Testing

Adenovirus, Boca Virus, Metapneumonia, RSV Detection and Differentiation RNA Detection Qualitative Test

Detects Adenovirus, Boca Virus, Metapneumonia, and RSV from a single sample using RNA detection. Helps diagnose common causes of respiratory infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Nasopharyngeal swab, throat swab, or sputum sample. Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 36-48 hours. Email notifications are sent within 4 working days. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Inform the laboratory if the patient is currently taking antiviral medications.
Test priceKSh 27,200

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Adenovirus, Boca Virus, Metapneumonia, RSV Detection and Differentiation RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms of respiratory infection (cough, fever, shortness of breath).
  • ✓Difficulty differentiating between common respiratory viruses.
  • ✓Patients with severe respiratory symptoms.
  • ✓Individuals at high risk for complications from respiratory infections.
  • ✓Monitoring outbreaks in specific populations (e.g., schools, care facilities).
02

In plain language

What this test helps you understand

This test aids in the diagnosis of viral respiratory infections caused by Adenovirus, Boca Virus, Metapneumonia, or RSV. Accurate identification allows clinicians to provide appropriate management and guidance, potentially reducing the need for unnecessary treatments like broad-spectrum antibiotics.
This test identifies the presence of Adenovirus, Boca Virus, Metapneumonia, and Respiratory Syncytial Virus (RSV) from a respiratory sample. It uses advanced Real Time PCR technology to accurately detect the genetic material (RNA) of these specific viruses. This comprehensive approach helps healthcare providers distinguish between different viral respiratory infections, leading to more targeted and effective patient care. Understanding which virus is causing the illness is important for managing symptoms and preventing potential complications.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Inform the laboratory if the patient is currently taking antiviral medications.
SampleNasopharyngeal swab, throat swab, or sputum sample. Confirm specific requirements with the laboratory before booking.
MethodologyReal Time Polymerase Chain Reaction (PCR) for qualitative detection of viral RNA.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of viral RNA but does not quantify the viral load. Results may be affected by improper sample collection or transport. A negative result does not rule out infection, especially if the sample was collected late in the illness.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects Adenovirus, Boca Virus, Metapneumonia, and Respiratory Syncytial Virus (RSV).
A sample is typically collected via a nasopharyngeal swab, throat swab, or sputum. Your doctor or a healthcare provider will determine the best method.
Results are usually available within 36-48 hours. You will receive an email notification within 4 working days.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
Yes, home sample collection is available in major cities across Kenya. Please call or WhatsApp +254711564616 to arrange.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp